⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
2026 RNAi Drug Delivery Market Report: Global Revenues to Reach $3.34 Billion by 2031, Driven by siRNA Approvals and Delivery Platform Innovation
globenewswire.com
ALNY
ARWR
ABUS
PFE
AZN
IONS
MRK
NVO
ROG
SNY
SLN
TAK
Brixton Biosciences Strengthens Board with Industry Veterans as Company Advances Towards Commercialization of Reneurx™ Nerve-Selective Therapy for Pain Associated with Knee Osteoarthritis
businesswire.com
ALNY
BIIB
ALL
ACT
ABBV
Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm
prnewswire.com
ALNY
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alnylam Pharmaceuticals, Inc. (ALNY) And Encourages Shareholders to Reach Out
accessnewswire.com
ALNY
Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm
globenewswire.com
ALNY
NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm
businesswire.com
ALNY
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alnylam Pharmaceuticals, Inc. (ALNY) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
ALNY
Alnylam Pharmaceuticals, Inc. (ALNY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ALNY
Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
globenewswire.com
ALNY
Alnylam Pharmaceuticals, Inc. (ALNY) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Continuing Securities Fraud Investigation
globenewswire.com
ALNY